Analysis of Antibody Response in Humans to the Type A OspC Loop 5 Domain and Assessment of the Potential Utility of the Loop 5 Epitope in Lyme Disease Vaccine Development

ABSTRACT The OspC protein of Borrelia burgdorferi is an immunodominant antigen. Here we demonstrate that the loop 5 domain of type A OspC is surface exposed, elicits bactericidal antibody in mice, and is antigenic in humans. The data suggest that loop 5 may be suitable for inclusion in a polyvalent, chimeric OspC vaccinogen.

[1]  K. Porter,et al.  Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen. , 2006, Vaccine.

[2]  J. Dumler,et al.  Demonstration of OspC Type Diversity in Invasive Human Lyme Disease Isolates and Identification of Previously Uncharacterized Epitopes That Define the Specificity of the OspC Murine Antibody Response , 2005, Infection and Immunity.

[3]  J. Langley,et al.  Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Jiyong Zhou,et al.  Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping. , 2005, Viral immunology.

[5]  M. Galinski,et al.  Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria. , 2005, Microbes and infection.

[6]  Chang-fa Fan,et al.  Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response. , 2005, Vaccine.

[7]  R. Schell,et al.  Borreliacidal OspC Antibodies Specific for a Highly Conserved Epitope Are Immunodominant in Human Lyme Disease and Do Not Occur in Mice or Hamsters , 2005, Clinical Diagnostic Laboratory Immunology.

[8]  D. Norris,et al.  Borrelia burgdorferi ospC Heterogeneity among Human and Murine Isolates from a Defined Region of Northern Maryland and Southern Pennsylvania: Lack of Correlation with Invasive and Noninvasive Genotypes , 2005, Journal of Clinical Microbiology.

[9]  James D. Campbell,et al.  Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial. , 2004, JAMA.

[10]  I. Toth,et al.  Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage. , 2004, Journal of medicinal chemistry.

[11]  G. Baranton,et al.  Genetic Diversity among Borrelia Strains Determined by Single-Strand Conformation Polymorphism Analysis of the ospC Gene and Its Association with Invasiveness , 2003, Journal of Clinical Microbiology.

[12]  M. Breitenbach,et al.  A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses. , 2003, Microbes and infection.

[13]  R. Schell,et al.  C-Terminal Region of Outer Surface Protein C Binds Borreliacidal Antibodies in Sera from Patients with Lyme Disease , 2003, Clinical Diagnostic Laboratory Immunology.

[14]  D. Roberts,et al.  Environmental Regulation and Differential Production of Members of the Bdr Protein Family of Borrelia burgdorferi , 2002, Infection and Immunity.

[15]  T. Klabunde,et al.  Crystal Structure of Lyme Disease Antigen Outer Surface Protein C from Borrelia burgdorferi * , 2001, The Journal of Biological Chemistry.

[16]  S. Swaminathan,et al.  Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi , 2001, The EMBO journal.

[17]  K. Matsui,et al.  Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies. , 2000, FEMS immunology and medical microbiology.

[18]  M. Mbow,et al.  An OspC-Specific Monoclonal Antibody Passively Protects Mice from Tick-Transmitted Infection by Borrelia burgdorferi B31 , 1999, Infection and Immunity.

[19]  D. Dykhuizen,et al.  Four Clones of Borrelia burgdorferiSensu Stricto Cause Invasive Infection in Humans , 1999, Infection and Immunity.

[20]  J. Dale.  Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. , 1999, Vaccine.

[21]  D. Dykhuizen,et al.  Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. , 1999, Genetics.

[22]  R. Schell,et al.  Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi. , 1998, The Journal of infectious diseases.

[23]  Ruth R. Montgomery,et al.  Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice , 1997, Infection and immunity.

[24]  J. Benach,et al.  Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy , 1997, Infection and immunity.

[25]  R. Lefebvre,et al.  Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. , 1997, The Journal of infectious diseases.

[26]  T. Burkot,et al.  Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC , 1996, Infection and immunity.

[27]  T. Schwan,et al.  Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Lefebvre,et al.  Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen , 1994, Infection and immunity.

[29]  J. Vuust,et al.  Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen , 1993, Journal of clinical microbiology.

[30]  A. Hofmann,et al.  Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi , 1993, Infection and immunity.

[31]  F. Lottspeich,et al.  Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22kDa protein (pC) in Escherichia coli , 1992, Molecular microbiology.

[32]  Gary J. Nabel,et al.  New Generation Vaccines , 1990 .